sc 53116 has been researched along with clebopride in 1 studies
| Studies (sc 53116) | Trials (sc 53116) | Recent Studies (post-2010) (sc 53116) | Studies (clebopride) | Trials (clebopride) | Recent Studies (post-2010) (clebopride) |
|---|---|---|---|---|---|
| 20 | 0 | 3 | 116 | 17 | 11 |
| Protein | Taxonomy | sc 53116 (IC50) | clebopride (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 0.89 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.017 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.6026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, I; Harada, H; Hirokawa, Y; Kato, S; Suzuki, K; Yoshida, N; Yoshikawa, T | 1 |
1 other study(ies) available for sc 53116 and clebopride
| Article | Year |
|---|---|
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Topics: Animals; Antiemetics; Azepines; Brain; Crystallography, X-Ray; Dogs; Dopamine Antagonists; Ferrets; In Vitro Techniques; Models, Molecular; Pyridines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 2003 |